Skip to content

Janux Therapeutics JANX Capital Lease Obligations Incurred

Capital Lease Obligations Incurred at other companies

DoubleVerify Holdings logo
DoubleVerify HoldingsDV
$13.81M
Willdan Group logo
Willdan GroupWLDN
$492K-15.2%
XPEL, Inc. logo
XPEL, Inc.XPEL
$158K-81.0%
Unitil logo
UnitilUTL
$100K
NB Bancorp, Inc. logo
NB Bancorp, Inc.NBBK
$124K-81.8%
ExlService Holdings logo
ExlService HoldingsEXLS
$217K-26.9%

Other financials

Income statement

See full
Revenue$3.7M
Operating income-$34.2M+2.0%
Net income-$24.4M-3.6%
EPS (diluted)-$0.39-2.6%

Balance sheet

See full
Cash & equivalents$51.8M-29.7%
Total debt$21.6M-4.6%
Total equity$941.5M-7.0%
Total assets$1.0B-2.1%

Cash flow

See full
Operating cash flow-$12.3M+27.5%
CapEx$273.0K-26.4%
Free cash flow-$12.6M+27.5%

Valuation

See full
Market cap$892.81M-36.1%
Enterprise value$862.55M-35.9%
P/S65×-84.6×

Profitability

See full
Operating margin-1,143.1%-65.1pp
Net margin-833.6%+0.9pp
FCF margin-571.6%+98.3pp

Returns & leverage

See full
Return on equity-11.7%+4.1pp
Debt / equity0.0×
Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CapitalLeaseObligationsIncurred.

The official record: Janux Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's capital lease obligations incurred.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janux Therapeutics's capital lease obligations incurred?
Janux Therapeutics (JANX) reported capital lease obligations incurred of $235.75K in Q4 2025.
What does capital lease obligations incurred mean?
This represents the total value of new capital lease obligations entered into by the company during the reporting period. It indicates the company's reliance on leasing rather than purchasing assets to support its operations, such as laboratory equipment or facilities. Monitoring this is essential for understanding the company's off-balance-sheet financing and long-term fixed obligation profile.